Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Conference Call March 2, 2023 8:45 AM ET Company Participants Lisa Caperelli - VP of IR William Collier - President and CEI Michael Sofia - Chief Scientific Officer David Hastings - CFO Michael McElhaugh - COO Conference Call Participants Dennis Ding - Jefferies Charles Moore - Baird Thomas Yip - H.C. Wainwright Keay Nakae - Chardan Roy Buchanan - JMP Securities Operator Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Co ...